LivaNova PLC Deferred Foreign Income Tax Expense (Benefit)
LivaNova PLC (LIVN) reported Deferred Foreign Income Tax Expense (Benefit) of -$4.63 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2026-02-25
- LivaNova PLC deferred foreign income tax expense (benefit) for fiscal 2025 was -$4.63M, a 673.51% decline from fiscal 2024.
- LivaNova PLC deferred foreign income tax expense (benefit) for fiscal 2024 was $808.00K.
- LivaNova PLC deferred foreign income tax expense (benefit) for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- LivaNova PLC deferred foreign income tax expense (benefit) for fiscal 2022 was $1.41M, a 50.60% decline from fiscal 2021.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 6 month | Deferred Foreign Income Tax Expense (Benefit) 8 month | Deferred Foreign Income Tax Expense (Benefit) 8 month as first filed | Deferred Foreign Income Tax Expense (Benefit) 12 month | Deferred Foreign Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | -$4.63M 10-K · filed 2026-02-25 | ||||
| 2024-12-31 | $808.00K 10-K · filed 2026-02-25 | $5.99M 10-K · filed 2025-02-25 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-02-25 | -$114.43M 10-K · filed 2024-02-29 | |||
| 2022-12-31 | $1.41M 10-K · filed 2025-02-25 | ||||
| 2021-12-31 | $2.85M 10-K · filed 2024-02-29 | ||||
| 2018-12-31 | -$81.10M 10-K · filed 2019-03-18 | ||||
| 2017-12-31 | $14.58M 10-K · filed 2019-03-18 | -$4.14M 10-K · filed 2018-02-28 | |||
| 2016-12-31 | $138.00K 10-K · filed 2019-03-18 | -$26.85M 10-K · filed 2017-03-01 | |||
| 2015-12-31 | -$18.69M 10-K · filed 2018-02-28 | -$20.19M 10-KT · filed 2016-03-04 | |||
| 2015-10-18 | -$43.89K 10-Q · filed 2015-12-08 | ||||
| 2015-04-24 | $834.00K 10-K · filed 2018-02-28 | ||||
| 2014-04-25 | -$3.53M 10-K · filed 2017-03-01 | ||||
| 2013-04-26 | $0.00 10-KT · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |